Malcolm Hoenlein, Director at KERYX BIOPHARMACEUTICALS INC (KERX), sold 7,000 shares at $13.26 ($93K) on 2006-12-29, disclosed to the SEC on 2006-12-29.
Open-market sale of $93k KERX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.16 | 2,000 | $26K | 28.4% |
| 2 | $13.26 | 5,000 | $66K | 71.6% |
| Total | $13.23 avg | 7,000 | $93K | 100% |